King of Prussia, PA, United States of America

Jeffrey Charles Boehm

USPTO Granted Patents = 48 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 3.9

ph-index = 14

Forward Citations = 671(Granted Patents)

Location History:

US (1997)
King of Prussia, PA (US) (1991 - 2020)

Company Filing History:

35 out of 2,198

Smithkline Beecham Corporation

Glaxosmithkline Intellectual Property Development Limited

patents

5. 3 out of 123

Astex Therapeutics Limited

patents

6. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1991-2020

Loading Chart...

48 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10604509 - Nrf2 regulators (2020-03-31),

2. 10485806 - Nrf2 regulators (2019-11-26),

3. 10272095 - NRF2 regulators (2019-04-30),

4. 8354416 - 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase (2013-01-15),

5. 8207176 - Compounds (2012-06-26),

6. 8071584 - Indole carboxamides as IKK2 inhibitors (2011-12-06),

7. 8058282 - 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy (2011-11-15),

8. 7759486 - 2,4,5-Trisubstituted pyrimidine compounds (2010-07-20),

9. 7700768 - Compounds (2010-04-20),

10. 7678801 - Compounds (2010-03-16),

11. 7629462 - Tetrasubstituted pyrimidine compounds as chemical intermediates (2009-12-08),

12. 7629350 - Compounds (2009-12-08),

13. 7550480 - Compounds (2009-06-23),

14. 7479558 - [object Object] (2009-01-20),

15. 7423042 - Compounds (2008-09-09),

Title: The Inventive Journey of Jeffrey Charles Boehm

Introduction:

Jeffrey Charles Boehm, a prolific inventor based in King of Prussia, PA (US), has made significant contributions to the field of pharmaceuticals with an impressive total of 47 patents to his name.

Latest Patents:

Boehm's latest patents focus on Nrf2 regulators, specifically aryl analogs. These patents highlight the development of pharmaceutical compositions containing these analogs and their use as NRF2 regulators, showcasing Boehm's innovative approach to drug discovery.

Career Highlights:

Throughout his career, Jeffrey Charles Boehm has lent his expertise to renowned companies such as SmithKline Beecham Corporation and Glaxo Group Limited. His tenure at these esteemed organizations has undoubtedly influenced his innovative work in the pharmaceutical industry.

Collaborations:

Boehm has collaborated with notable peers in the field, including Jerry Leroy Adams and Timothy Francis Gallagher. These collaborations have led to the successful development of groundbreaking pharmaceutical technologies, further solidifying Boehm's reputation as a leading inventor in his field.

Conclusion:

In conclusion, Jeffrey Charles Boehm's extensive patent portfolio and his collaborations with industry experts underscore his significant impact on the field of pharmaceutical innovation. His pioneering work in Nrf2 regulators serves as a testament to his commitment to advancing drug discovery and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.